Back

Treatment patterns in a population of 1.4 million individuals qualifying for initiation of dual-combination blood pressure lowering therapy representing usual clinical practice.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Hypertension management and risk factors Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Antonio Coca

Hospital Clinic, University of Barcelona, Barcelona (Spain)

7 More presentations in this session

Presentation thumbnail
A physiologic, precision-medicine approach to guided pharmacological treatment of hypertension substantially improves blood pressure in a large community-based cohort
Doctor D. Romer (Dayton, US)
Abstract Slides Video
Presentation thumbnail
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
Professor G. Khamidullaeva (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Severity of obstructive sleep apnea is associated with left ventricular abnormality in patients with hypertension in the young
Professor S. Silaruks (Khon Kaen, TH)
Abstract Slides Video
Presentation thumbnail
Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing
Doctor S. Ueba (Maebashi, JP)
Abstract Slides Video
Presentation thumbnail
Performance of a cuffless blood pressure monitor in the adult and elderly population - a comparative validation study
Doctor G. Wuerzner (Lausanne, CH)
Abstract Slides

Access the full session

Session thumbnail
Hypertension management and risk factors

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources